{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:10:46Z","timestamp":1763766646132,"version":"3.45.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc. Diabetol. \u2013 Endocrinol. Rep."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic neuropathy is the debilitating most common and expensive complication of diabetes that can cause significant mortality and morbidity, resulting from foot ulceration, lower extremity amputation, and pain that reduces the quality of life. The majority of type II diabetes mellitus patients continue to develop diabetic neuropathy despite optimal glycemic control, and the identification of predictors for diabetic neuropathy is important. Thus, this study aimed to determine the predictors of diabetic neuropathy in patients with type II diabetes mellitus in Ethiopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A hospital-based retrospective longitudinal follow-up study was conducted from January 2012 to December 2021 in patients with type II diabetes. Simple random sampling was used to select study participants, and data were collected by reviewing the medical records. Stata version 14 was used for the statistical analysis. A bivariable and multivariable Cox regression analysis was performed to identify predictors of diabetic neuropathy. The goodness of the model fitness was checked via the Cox-Snell residual. A\n                      <jats:italic>p<\/jats:italic>\n                      -value less than 0.05 was used to declare the statistical significance of the variables.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The incidence density of diabetic neuropathy was 3.56 cases per 1,000 person months of observation, and the median time to develop diabetic neuropathy was 105 months. Advanced age (adjusted hazard ratio (AHR) 1.03 (95% CI: 1.01, 1.06)) and total cholesterol\u2009\u2265\u2009200\u00a0mg\/dl (AHR 2.52 (95% CI: 1.25, 5.09)) were statistically significant predictors of diabetic neuropathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Advanced age and hypercholesterolemia were significantly associated predictors with diabetic neuropathy. Healthcare providers need to monitor cholesterol levels in order to prevent or delay diabetic neuropathy development in patients with type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40842-025-00241-9","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:02:23Z","timestamp":1763766143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advanced age and elevated cholesterol predict diabetic neuropathy in patients with type II diabetes mellitus in Southern Ethiopia"],"prefix":"10.1186","volume":"11","author":[{"given":"Fasika","family":"Merid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habtamu","family":"Esubalew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamirat Gezahegn","family":"Guyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firdawek","family":"Getahun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"key":"241_CR1","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium. 2021. Available online from: https:\/\/www.diabetesatlas.org"},{"key":"241_CR2","unstructured":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet (London England). 2023;402(10397):203\u201334."},{"issue":"1","key":"241_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","volume":"10","author":"MAB Khan","year":"2020","unstructured":"Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes - global burden of disease and forecasted trends. J Epidemiol Global Health. 2020;10(1):107\u201311.","journal-title":"J Epidemiol Global Health"},{"key":"241_CR4","doi-asserted-by":"crossref","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17).","DOI":"10.3390\/ijms21176275"},{"issue":"4","key":"241_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/1573403X1604201229115531","volume":"16","author":"P Farmaki","year":"2020","unstructured":"Farmaki P, Damaskos C, Garmpis N, Garmpi A, Savvanis S, Diamantis E. Complications of the type 2 diabetes mellitus. Curr Cardiol Rev. 2020;16(4):249\u201351.","journal-title":"Curr Cardiol Rev"},{"issue":"1\u201302","key":"241_CR6","first-page":"72","volume":"131","author":"D Ziegler","year":"2023","unstructured":"Ziegler D, Keller J, Maier C, Pannek J. Diabetic neuropathy. Experimental and clinical endocrinology & diabetes: official journal. German Soc Endocrinol [and] German Diabetes Association. 2023;131(1\u201302):72\u201383.","journal-title":"German Soc Endocrinol [and] German Diabetes Association"},{"key":"241_CR7","doi-asserted-by":"publisher","first-page":"671257","DOI":"10.3389\/fendo.2021.671257","volume":"12","author":"J Carmichael","year":"2021","unstructured":"Carmichael J, Fadavi H, Ishibashi F, Shore AC, Tavakoli M. Advances in screening, early diagnosis and accurate staging of diabetic neuropathy. Front Endocrinol. 2021;12:671257.","journal-title":"Front Endocrinol"},{"key":"241_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-820669-0.00014-1","volume-title":"Classification, risk factors, and clinical presentation diabetic neuropathy","author":"DG Yavuz","year":"2022","unstructured":"Yavuz DG. Classification, risk factors, and clinical presentation diabetic neuropathy. Diabetic neuropathy: Elsevier; 2022:1\u20139."},{"key":"241_CR9","doi-asserted-by":"publisher","first-page":"1265372","DOI":"10.3389\/fendo.2023.1265372","volume":"14","author":"J Zhu","year":"2024","unstructured":"Zhu J, Hu Z, Luo Y, Liu Y, Luo W, Du X, et al. Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. Front Endocrinol. 2024;14:1265372.","journal-title":"Front Endocrinol"},{"key":"241_CR10","unstructured":"Bodman MA, Dreyer MA, Varacallo M. Diabetic peripheral neuropathy. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Mark Dreyer declares no relevant financial relationships with ineligible companies. Disclosure: Matthew Varacallo declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright \u00a9. 2024, StatPearls Publishing LLC.; 2024."},{"key":"241_CR11","unstructured":"de Souza LR, Debiasi D, Ceretta LB, Sim\u00c3\u00b5es PW, Tuon L. Meta-analysis and meta-regression of the prevalence of diabetic peripheral neuropathy among patients with type 2 diabetes mellitus. Int Archives Med. 2016;9."},{"issue":"1","key":"241_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12902-020-0534-5","volume":"20","author":"WS Shiferaw","year":"2020","unstructured":"Shiferaw WS, Akalu TY, Work Y, Aynalem YA. Prevalence of diabetic peripheral neuropathy in africa: a systematic review and meta-analysis. BMC Endocr Disorders. 2020;20(1):49.","journal-title":"BMC Endocr Disorders"},{"key":"241_CR13","doi-asserted-by":"publisher","first-page":"5304124","DOI":"10.1155\/2021\/5304124","volume":"2021","author":"DB Tadesse","year":"2021","unstructured":"Tadesse DB, Gebrewahd GT, Hailay A, Aberhe W, Mebrahtom G, Zereabruk K, et al. Diabetic peripheral neuropathy in Ethiopia: a systematic review and Meta-Analysis. J Diabetes Res. 2021;2021:5304124.","journal-title":"J Diabetes Res"},{"key":"241_CR14","doi-asserted-by":"crossref","unstructured":"Gandhi M, Fargo E, Prasad-Reddy L, Mahoney KM, Isaacs D. Diabetes: how to manage diabetic peripheral neuropathy. Drugs Context. 2022;11.","DOI":"10.7573\/dic.2021-10-2"},{"issue":"1","key":"241_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41572-019-0097-9","volume":"5","author":"EL Feldman","year":"2019","unstructured":"Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nat Reviews Disease Primers. 2019;5(1):42.","journal-title":"Nat Reviews Disease Primers"},{"key":"241_CR16","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3389\/fendo.2019.00929","volume":"10","author":"H Yang","year":"2019","unstructured":"Yang H, Sloan G, Ye Y, Wang S, Duan B, Tesfaye S, et al. New perspective in diabetic neuropathy: from the periphery to the brain, a call for early detection, and precision medicine. Front Endocrinol. 2019;10:929.","journal-title":"Front Endocrinol"},{"key":"241_CR17","doi-asserted-by":"crossref","unstructured":"Burgess J, Frank B, Marshall A, Khalil RS, Ponirakis G, Petropoulos IN et al. Early detection of diabetic peripheral neuropathy: a focus on small nerve fibres. Diagnostics (Basel Switzerland). 2021;11(2).","DOI":"10.3390\/diagnostics11020165"},{"issue":"6","key":"241_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","volume":"11","author":"BC Callaghan","year":"2012","unstructured":"Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521\u201334.","journal-title":"Lancet Neurol"},{"issue":"10","key":"241_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11892-019-1212-8","volume":"19","author":"CW Hicks","year":"2019","unstructured":"Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep. 2019;19(10):86.","journal-title":"Curr Diab Rep"},{"issue":"1","key":"241_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/jvd1010003","volume":"1","author":"ME Elhefnawy","year":"2022","unstructured":"Elhefnawy ME, Ghadzi SMS, Noor Harun S. Predictors associated with type 2 diabetes mellitus complications over time: a literature review. J Vascular Dis. 2022;1(1):13\u201323.","journal-title":"J Vascular Dis"},{"issue":"6","key":"241_CR21","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","volume":"93","author":"EL Feldman","year":"2017","unstructured":"Feldman EL, Nave KA, Jensen TS, Bennett DLH. New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain. Neuron. 2017;93(6):1296\u2013313.","journal-title":"Neuron"},{"key":"241_CR22","doi-asserted-by":"publisher","unstructured":"Pop-Busui R, Ang L, Boulton AJM, American Diabetes Association. Diagnosis and treatment of painful diabetic peripheral neuropathy. Arlington (VA): 2022 Feb. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK580224\/https:\/\/doi.org\/10.2337\/db2022-01","DOI":"10.2337\/db2022-01"},{"issue":"8","key":"241_CR23","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3390\/life12081185","volume":"12","author":"S Smith","year":"2022","unstructured":"Smith S, Normahani P, Lane T, Hohenschurz-Schmidt D, Oliver N, Davies AH. Prevention and management strategies for diabetic neuropathy. Life. 2022;12(8):1185.","journal-title":"Life"},{"issue":"4","key":"241_CR24","doi-asserted-by":"publisher","first-page":"e0284568","DOI":"10.1371\/journal.pone.0284568","volume":"18","author":"S Tantigegn","year":"2023","unstructured":"Tantigegn S, Ewunetie AA, Agazhe M, Aschale A, Gebrie M, Diress G, et al. Time to diabetic neuropathy and its predictors among adult type 2 diabetes mellitus patients in Amhara regional state comprehensive specialized hospitals, Northwest Ethiopia, 2022: a retrospective follow up study. PLoS ONE. 2023;18(4):e0284568.","journal-title":"PLoS ONE"},{"key":"241_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41983-021-00402-4","volume":"57","author":"SA Kebede","year":"2021","unstructured":"Kebede SA, Tusa BS, Weldesenbet AB, Tessema ZT, Ayele TA. Time to diabetic neuropathy and its predictors among newly diagnosed type 2 diabetes mellitus patients in Northwest Ethiopia. Egypt J Neurol Psychiatry Neurosurg. 2021;57:1\u20137.","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"241_CR26","doi-asserted-by":"crossref","unstructured":"An J, Nichols GA, Qian L, Munis MA, Harrison TN, Li Z et al. Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes. BMJ Open Diabetes Res Care. 2021;9(1).","DOI":"10.1136\/bmjdrc-2020-001847"},{"issue":"5","key":"241_CR27","first-page":"1058","volume":"34","author":"A Fawwad","year":"2018","unstructured":"Fawwad A, Mustafa N, Zafar AB, Khalid M. Incidence of microvascular complications of type 2 diabetes: a 12 year longitudinal study from Karachi-Pakistan. Pakistan J Med Sci. 2018;34(5):1058\u201363.","journal-title":"Pakistan J Med Sci"},{"issue":"6","key":"241_CR28","doi-asserted-by":"publisher","first-page":"741","DOI":"10.4239\/wjd.v14.i6.741","volume":"14","author":"CAN Ismail","year":"2023","unstructured":"Ismail CAN. Issues and challenges in diabetic neuropathy management: a narrative review. World J Diabetes. 2023;14(6):741\u201357.","journal-title":"World J Diabetes"},{"key":"241_CR29","doi-asserted-by":"publisher","first-page":"1220896","DOI":"10.3389\/fendo.2023.1220896","volume":"14","author":"M Tavakoli","year":"2023","unstructured":"Tavakoli M, Klingelh\u00f6fer D, Fadavi H, Groneberg DA. The landscape of global research on diabetic neuropathy. Front Endocrinol. 2023;14:1220896.","journal-title":"Front Endocrinol"},{"issue":"6","key":"241_CR30","doi-asserted-by":"publisher","first-page":"508","DOI":"10.24171\/j.phrp.2023.0084","volume":"14","author":"N Sauenram","year":"2023","unstructured":"Sauenram N, Sillabutra J, Viwatwongkasem C, Satitvipawee P. Estimation of the onset time of diabetic complications in type 2 diabetes patients in thailand: a survival analysis. Osong Public Health Res Perspect. 2023;14(6):508\u201319.","journal-title":"Osong Public Health Res Perspect"},{"issue":"6","key":"241_CR31","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/jdi.12223","volume":"5","author":"D Bansal","year":"2014","unstructured":"Bansal D, Gudala K, Muthyala H, Esam HP, Nayakallu R, Bhansali A. Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J Diabetes Invest. 2014;5(6):714\u201321.","journal-title":"J Diabetes Invest"},{"issue":"20","key":"241_CR32","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.3889\/oamjms.2019.433","volume":"7","author":"R Amelia","year":"2019","unstructured":"Amelia R, Wahyuni AS, Yunanda Y. Diabetic neuropathy among type 2 diabetes mellitus patients at amplas primary health care in Medan City. Open Access Macedonian J Med Sci. 2019;7(20):3400.","journal-title":"Open Access Macedonian J Med Sci"},{"key":"241_CR33","doi-asserted-by":"publisher","first-page":"934020","DOI":"10.3389\/fendo.2022.934020","volume":"13","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Cao W, Zhang J, Wang J, Liu X, Wu Q, et al. Determinants of diabetic peripheral neuropathy and their clinical significance: a retrospective cohort study. Front Endocrinol. 2022;13:934020.","journal-title":"Front Endocrinol"},{"key":"241_CR34","doi-asserted-by":"publisher","first-page":"577574","DOI":"10.1016\/j.jneuroim.2021.577574","volume":"355","author":"KM Hagen","year":"2021","unstructured":"Hagen KM, Ousman SS. Aging and the immune response in diabetic peripheral neuropathy. J Neuroimmunol. 2021;355:577574.","journal-title":"J Neuroimmunol"},{"issue":"6","key":"241_CR35","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2165\/00002512-199608060-00003","volume":"8","author":"J Belmin","year":"1996","unstructured":"Belmin J, Valensi P. Diabetic neuropathy in elderly patients. What Can Be Done?? Drugs Aging. 1996;8(6):416\u201329.","journal-title":"What Can Be Done?? Drugs Aging"},{"key":"241_CR36","doi-asserted-by":"crossref","unstructured":"Alshammari NA, Alodhayani AA, Joy SS, Isnani A, Mujammami M, Alfadda AA et al. Evaluation of risk factors for diabetic peripheral neuropathy among Saudi type 2 diabetic patients with longer duration of diabetes. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2022:3007-14.","DOI":"10.2147\/DMSO.S364933"},{"issue":"1","key":"241_CR37","first-page":"25","volume":"27","author":"F Al-Mahroos","year":"2007","unstructured":"Al-Mahroos F, Al-Roomi K. Diabetic neuropathy, foot ulceration, peripheral vascular disease and potential risk factors among patients with diabetes in bahrain: a nationwide primary care diabetes clinic-based study. Ann Saudi Med. 2007;27(1):25\u201331.","journal-title":"Ann Saudi Med"},{"key":"241_CR38","first-page":"57","volume":"10","author":"S Rajbhandari","year":"2008","unstructured":"Rajbhandari S. Lipids and diabetic neuropathy: a review. Diabetes Prim Care. 2008;10:57.","journal-title":"Diabetes Prim Care"},{"issue":"10","key":"241_CR39","first-page":"e19142","volume":"13","author":"R Luna","year":"2021","unstructured":"Luna R, Talanki Manjunatha R, Bollu B, Jhaveri S, Avanthika C, Reddy N, et al. A comprehensive review of neuronal changes in diabetics. Cureus. 2021;13(10):e19142.","journal-title":"Cureus"}],"container-title":["Cardiovascular Diabetology \u2013 Endocrinology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-025-00241-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40842-025-00241-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-025-00241-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:02:26Z","timestamp":1763766146000},"score":1,"resource":{"primary":{"URL":"https:\/\/clindiabetesendo.biomedcentral.com\/articles\/10.1186\/s40842-025-00241-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["241"],"URL":"https:\/\/doi.org\/10.1186\/s40842-025-00241-9","relation":{},"ISSN":["3059-4057"],"issn-type":[{"value":"3059-4057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"28 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"An ethical approval letter was obtained from the institutional review board of Arba Minch University. The requirement of informed consent for reviewing a patient\u2019s medical chart was waived by the institutional review board of Arba Minch University because of the retrospective nature of the study design. The study was performed in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}